These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 24138599)

  • 1. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
    Bekkering P; Jafri I; van Overveld FJ; Rijkers GT
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1031-41. PubMed ID: 24138599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
    McPhee JB; Schertzer JD
    Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of gut microbiota in the pathogenesis of obesity and diabetes].
    Stachowicz N; Kiersztan A
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():288-303. PubMed ID: 23619228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes.
    Zipris D
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):265-70. PubMed ID: 23743644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the level of bacterial exposure in early life impact the risk of Type 1 diabetes?
    Abela AG; Fava S
    Expert Rev Clin Immunol; 2013 Aug; 9(8):695-7. PubMed ID: 23971746
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
    Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
    Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.